ATE346923T1 - Ly6h-gen - Google Patents
Ly6h-genInfo
- Publication number
- ATE346923T1 ATE346923T1 AT99943357T AT99943357T ATE346923T1 AT E346923 T1 ATE346923 T1 AT E346923T1 AT 99943357 T AT99943357 T AT 99943357T AT 99943357 T AT99943357 T AT 99943357T AT E346923 T1 ATE346923 T1 AT E346923T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- expression vector
- product
- ly6h
- gen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26355098 | 1998-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE346923T1 true ATE346923T1 (de) | 2006-12-15 |
Family
ID=17391112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99943357T ATE346923T1 (de) | 1998-09-17 | 1999-09-16 | Ly6h-gen |
Country Status (17)
Country | Link |
---|---|
US (4) | US7432363B2 (de) |
EP (1) | EP1114861B8 (de) |
JP (1) | JP4403443B2 (de) |
KR (1) | KR100640265B1 (de) |
CN (1) | CN1240834C (de) |
AT (1) | ATE346923T1 (de) |
AU (1) | AU767878B2 (de) |
BR (1) | BR9913850A (de) |
CA (1) | CA2342770C (de) |
CY (1) | CY1107552T1 (de) |
DE (1) | DE69934239T8 (de) |
DK (1) | DK1114861T3 (de) |
ES (1) | ES2276531T3 (de) |
HK (1) | HK1038380A1 (de) |
ID (1) | ID29573A (de) |
PT (1) | PT1114861E (de) |
WO (1) | WO2000017345A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69934239T8 (de) * | 1998-09-17 | 2007-12-06 | Otsuka Pharmaceutical Co., Ltd. | Ly6h-gen |
IL160307A0 (en) * | 2001-08-31 | 2004-07-25 | Univ Rockefeller | Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
CN101506236B (zh) | 2005-11-30 | 2012-12-12 | 雅培制药有限公司 | 抗淀粉样β蛋白的单克隆抗体及其用途 |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
WO2008103962A2 (en) * | 2007-02-22 | 2008-08-28 | Genentech, Inc. | Methods for detecting inflammatory bowel disease |
EP2486928A1 (de) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Verfahren zur Behandlung von Amyloidosen |
SG10201507362TA (en) | 2009-08-05 | 2015-10-29 | Intra Cellular Therapies Inc | Novel Regulatory Proteins And Inhibitors |
MX360403B (es) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Proteinas de union a amiloide beta. |
JP6147665B2 (ja) | 2010-08-14 | 2017-06-14 | アッヴィ・インコーポレイテッド | アミロイドベータ結合タンパク質 |
US20140286910A1 (en) * | 2013-03-19 | 2014-09-25 | Nikolai Tankovich | Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity |
CN105385754B (zh) * | 2015-10-28 | 2018-11-06 | 北京泱深生物信息技术有限公司 | 一种与胆管癌相关的分子标记物 |
KR102232200B1 (ko) * | 2019-03-13 | 2021-03-25 | 아주대학교산학협력단 | 알츠하이머치매 진단 바이오마커 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011912A (en) * | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
JPH0348696A (ja) * | 1989-07-14 | 1991-03-01 | Toray Ind Inc | ヒトリンパ球表面抗原およびそれをコードする遺伝子 |
WO1997018224A1 (en) * | 1995-11-13 | 1997-05-22 | Human Genome Sciences, Inc. | Human stem cell antigen 2 |
AU2095299A (en) * | 1997-12-31 | 1999-07-19 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
DE69934239T8 (de) * | 1998-09-17 | 2007-12-06 | Otsuka Pharmaceutical Co., Ltd. | Ly6h-gen |
-
1999
- 1999-09-16 DE DE69934239T patent/DE69934239T8/de active Active
- 1999-09-16 PT PT99943357T patent/PT1114861E/pt unknown
- 1999-09-16 JP JP2000574245A patent/JP4403443B2/ja not_active Expired - Fee Related
- 1999-09-16 KR KR1020017003354A patent/KR100640265B1/ko not_active IP Right Cessation
- 1999-09-16 AT AT99943357T patent/ATE346923T1/de active
- 1999-09-16 CN CNB998110191A patent/CN1240834C/zh not_active Expired - Fee Related
- 1999-09-16 AU AU56518/99A patent/AU767878B2/en not_active Ceased
- 1999-09-16 DK DK99943357T patent/DK1114861T3/da active
- 1999-09-16 CA CA2342770A patent/CA2342770C/en not_active Expired - Fee Related
- 1999-09-16 EP EP99943357A patent/EP1114861B8/de not_active Expired - Lifetime
- 1999-09-16 WO PCT/JP1999/005039 patent/WO2000017345A1/ja active IP Right Grant
- 1999-09-16 BR BR9913850-6A patent/BR9913850A/pt not_active Application Discontinuation
- 1999-09-16 ES ES99943357T patent/ES2276531T3/es not_active Expired - Lifetime
- 1999-09-16 ID IDW20010739A patent/ID29573A/id unknown
-
2001
- 2001-12-28 HK HK01109195A patent/HK1038380A1/xx not_active IP Right Cessation
-
2003
- 2003-12-23 US US10/743,018 patent/US7432363B2/en not_active Expired - Fee Related
-
2007
- 2007-02-02 CY CY20071100152T patent/CY1107552T1/el unknown
-
2008
- 2008-02-15 US US12/032,012 patent/US20090017479A1/en not_active Abandoned
- 2008-07-03 US US12/167,288 patent/US7582732B2/en not_active Expired - Fee Related
- 2008-09-30 US US12/242,370 patent/US20100261880A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69934239D1 (de) | 2007-01-11 |
AU5651899A (en) | 2000-04-10 |
BR9913850A (pt) | 2001-10-23 |
US20100261880A1 (en) | 2010-10-14 |
US7582732B2 (en) | 2009-09-01 |
US20090017479A1 (en) | 2009-01-15 |
CN1240834C (zh) | 2006-02-08 |
EP1114861B8 (de) | 2008-10-01 |
US20040254340A1 (en) | 2004-12-16 |
US20080275218A1 (en) | 2008-11-06 |
DE69934239T8 (de) | 2007-12-06 |
AU767878B2 (en) | 2003-11-27 |
CY1107552T1 (el) | 2013-03-13 |
WO2000017345A1 (fr) | 2000-03-30 |
DK1114861T3 (da) | 2007-03-19 |
EP1114861A4 (de) | 2004-10-13 |
US7432363B2 (en) | 2008-10-07 |
EP1114861A1 (de) | 2001-07-11 |
JP4403443B2 (ja) | 2010-01-27 |
KR100640265B1 (ko) | 2006-10-31 |
CA2342770A1 (en) | 2000-03-30 |
CA2342770C (en) | 2011-06-21 |
DE69934239T2 (de) | 2007-06-28 |
ID29573A (id) | 2001-09-06 |
PT1114861E (pt) | 2007-01-31 |
KR20010085801A (ko) | 2001-09-07 |
CN1318099A (zh) | 2001-10-17 |
HK1038380A1 (en) | 2002-03-15 |
ES2276531T3 (es) | 2007-06-16 |
EP1114861B1 (de) | 2006-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107552T1 (el) | Ly6h γονιδιο | |
WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
DE69636866D1 (en) | Reverse "two-hybrid"-systeme | |
CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
ATE394484T1 (de) | Smad 6 und dessen anwendungen | |
DE69635207D1 (de) | Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist. | |
IL135688A0 (en) | Human checkpoint kinase, hcds1, compositions and methods | |
WO2003011898A3 (fr) | Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations | |
WO2002004677A8 (en) | Methods for diagnosis and treatment of psychiatric disorders | |
WO2000003004A3 (en) | Presenilin 2 specific ribozyme | |
WO1997002730A3 (en) | Enamel matrix related polypeptide | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
EP1090995A3 (de) | Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen | |
WO2004003170A3 (en) | Agents capable of inhibiting ras and uses thereof | |
WO2000008143A3 (de) | Gen isoliert auf dem kurzen arm des menschlichen chromosoms 17 | |
IL142664A0 (en) | Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same | |
AU2002350406A1 (en) | Identification of ses-3 (spr-5) in c. elegans and the uses of the same | |
ATE198218T1 (de) | Htfiiia gen | |
AU2002314193A1 (en) | Identification of ses-1 and the uses of the same | |
WO2002000827A3 (fr) | Nouveau polypeptide, proteine de methylation d'adn-cysteine methyl-transferase 10, et polynucleotide codant ce polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1114861 Country of ref document: EP |